Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.

BACKGROUND: Microbubbles (MBs) can serve as an ultrasound contrast agent, and has the potential for magnetic resonance imaging (MRI). Due to the relatively low effect of MBs on MRI, it is necessary to develop new MBs that are more suitable for MRI. In this study, we evaluate the properties of SonoVu...

Full description

Bibliographic Details
Main Authors: Ling Li, Qiang Wei, Hong-Bo Li, Song Wen, Gao-Jun Teng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3323543?pdf=render
_version_ 1828388305810489344
author Ling Li
Qiang Wei
Hong-Bo Li
Song Wen
Gao-Jun Teng
author_facet Ling Li
Qiang Wei
Hong-Bo Li
Song Wen
Gao-Jun Teng
author_sort Ling Li
collection DOAJ
description BACKGROUND: Microbubbles (MBs) can serve as an ultrasound contrast agent, and has the potential for magnetic resonance imaging (MRI). Due to the relatively low effect of MBs on MRI, it is necessary to develop new MBs that are more suitable for MRI. In this study, we evaluate the properties of SonoVue® and custom-made Fe(3)O(4)-nanoparticle-embedded microbubbles (Fe(3)O(4)-MBs) in terms of contrast agents for ultrsonography (US) and MRI. METHODOLOGY/PRINCIPAL FINDINGS: A total of 20 HepG2 subcutaneous-tumor-bearing nude mice were randomly assigned to 2 groups (i.e., n = 10 mice each group), one for US test and the other for MRI test. Within each group, two tests were performed for each mouse. The contrast agent for the first test is SonoVue®, and the second is Fe(3)O(4)-MBs. US was performed using a Technos(MPX) US system (Esaote, Italy) with a contrast-tuned imaging (CnTI™) mode. MRI was performed using a 7.0T Micro-MRI (PharmaScan, Bruker Biospin GmbH, Germany) with an EPI-T(2)* sequence. The data of signal-to-noise ratio (SNR) from the region-of-interest of each US and MR image was calculated by ImageJ (National Institute of Health, USA). In group 1, enhancement of SonoVue® was significantly higher than Fe(3)O(4)-MBs on US (P<0.001). In group 2, negative enhancement of Fe(3)O(4)-MBs was significantly higher than SonoVue® on MRI (P<0.001). The time to peak showed no significant differences between US and MRI, both of which used the same MBs (P>0.05). The SNR analysis of the enhancement process reveals a strong negative correlation in both cases (i.e., SonoVue® r = -0.733, Fe(3)O(4)-MBs r = -0.903, with P<0.05). CONCLUSIONS: It might be important to change the Fe(3)O(4)-MBs' shell structure and/or the imagining strategy of US to improve the imaging quality of Fe(3)O(4)-MBs on US. As an intriguing prospect that can be detected by US and MRI, MBs are worthy of further study.
first_indexed 2024-12-10T06:10:43Z
format Article
id doaj.art-1d704eca5f244a1a87d9b83c39f2bc0e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T06:10:43Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1d704eca5f244a1a87d9b83c39f2bc0e2022-12-22T01:59:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0174e3464410.1371/journal.pone.0034644Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.Ling LiQiang WeiHong-Bo LiSong WenGao-Jun TengBACKGROUND: Microbubbles (MBs) can serve as an ultrasound contrast agent, and has the potential for magnetic resonance imaging (MRI). Due to the relatively low effect of MBs on MRI, it is necessary to develop new MBs that are more suitable for MRI. In this study, we evaluate the properties of SonoVue® and custom-made Fe(3)O(4)-nanoparticle-embedded microbubbles (Fe(3)O(4)-MBs) in terms of contrast agents for ultrsonography (US) and MRI. METHODOLOGY/PRINCIPAL FINDINGS: A total of 20 HepG2 subcutaneous-tumor-bearing nude mice were randomly assigned to 2 groups (i.e., n = 10 mice each group), one for US test and the other for MRI test. Within each group, two tests were performed for each mouse. The contrast agent for the first test is SonoVue®, and the second is Fe(3)O(4)-MBs. US was performed using a Technos(MPX) US system (Esaote, Italy) with a contrast-tuned imaging (CnTI™) mode. MRI was performed using a 7.0T Micro-MRI (PharmaScan, Bruker Biospin GmbH, Germany) with an EPI-T(2)* sequence. The data of signal-to-noise ratio (SNR) from the region-of-interest of each US and MR image was calculated by ImageJ (National Institute of Health, USA). In group 1, enhancement of SonoVue® was significantly higher than Fe(3)O(4)-MBs on US (P<0.001). In group 2, negative enhancement of Fe(3)O(4)-MBs was significantly higher than SonoVue® on MRI (P<0.001). The time to peak showed no significant differences between US and MRI, both of which used the same MBs (P>0.05). The SNR analysis of the enhancement process reveals a strong negative correlation in both cases (i.e., SonoVue® r = -0.733, Fe(3)O(4)-MBs r = -0.903, with P<0.05). CONCLUSIONS: It might be important to change the Fe(3)O(4)-MBs' shell structure and/or the imagining strategy of US to improve the imaging quality of Fe(3)O(4)-MBs on US. As an intriguing prospect that can be detected by US and MRI, MBs are worthy of further study.http://europepmc.org/articles/PMC3323543?pdf=render
spellingShingle Ling Li
Qiang Wei
Hong-Bo Li
Song Wen
Gao-Jun Teng
Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
PLoS ONE
title Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
title_full Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
title_fullStr Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
title_full_unstemmed Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
title_short Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
title_sort evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging
url http://europepmc.org/articles/PMC3323543?pdf=render
work_keys_str_mv AT lingli evaluationofmicrobubblesascontrastagentsforultrasonographyandmagneticresonanceimaging
AT qiangwei evaluationofmicrobubblesascontrastagentsforultrasonographyandmagneticresonanceimaging
AT hongboli evaluationofmicrobubblesascontrastagentsforultrasonographyandmagneticresonanceimaging
AT songwen evaluationofmicrobubblesascontrastagentsforultrasonographyandmagneticresonanceimaging
AT gaojunteng evaluationofmicrobubblesascontrastagentsforultrasonographyandmagneticresonanceimaging